1 hour ago
This late-breaking, phase 2 data highlights nemolizumab's clinically meaningful benefits for children with moderate-to-severe atopic dermatitis.
4 hours ago
HI-PEITHO concluded use of ultrasound-facilitated catheter-directed fibrinolysis improves pulmonary embolism outcomes.
4 hours ago
7 hours ago
Soung discussed how new 52-week data support icotrokinra's recent FDA approval, marketed as Icotyde.
9 hours ago
REMODEL offers new mechanistic insights into semaglutide, highlighting microvascular and endothelial effects that help explain its kidney and cardiovascular benefits.